Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)

PHASE3CompletedINTERVENTIONAL
Enrollment

10,154

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

October 31, 2008

Study Completion Date

January 31, 2009

Conditions
Preeclampsia
Interventions
DRUG

Dietary Supplement/Vitamins

Vitamin C (1000 mg) and Vitamin E (400 IU) per capsule, two capsules daily between randomization (at 9 - 16 weeks gestation) up to delivery.

DRUG

Placebo for Vitamin C and Vitamin E

Placebo two capsules daily between randomization (at 9 - 16 weeks gestation) up to delivery.

Trial Locations (16)

10032

Columbia University, New York

15213

University of Pittsburgh Magee Womens Hospital, Pittsburgh

19107

Drexel University, Philadelphia

27157

Wake Forest University School of Medicine, Winston-Salem

27599

University of North Carolina - Chapel Hill, Chapel Hill

35233

University of Alabama - Birmingham, Birmingham

43210

Ohio State University, Columbus

44109

Case Western University, Cleveland

48201

Wayne State University, Detroit

60611

Northwestern University, Chicago

75235

University of Texas - Southwest, Dallas

77030

University of Texas - Houston, Houston

77555

University of Texas Medical Branch, Galveston

84132

University of Utah Medical Center, Salt Lake City

97239

Oregon Health and Sciences University, Portland

02905

Brown University, Providence

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

The George Washington University Biostatistics Center

OTHER

NCT00135707 - Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS) | Biotech Hunter | Biotech Hunter